Cost-effectiveness analysis of initial treatment with single-pill combination antihypertensive medications-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of initial treatment with single-pill combination antihypertensive medications

Published:2023-02-15 Issue:11 Volume:37 Page:985-992
ISSN:1476-5527
Container-title:Journal of Human Hypertension
language:en
Short-container-title:J Hum Hypertens

Author:

Bryan Alexis S.,Moran Andrew E.^ORCID,Mobley Claire M.,Derington Catherine G.^ORCID,Rodgers Anthony,Zhang Yiyi^ORCID,Fontil Valy,Shea Steven,Bellows Brandon K.^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41371-023-00811-3.pdf

Reference37 articles.

1. Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB, et al. Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018. JAMA. 2020;324:1190–1200. https://doi.org/10.1001/jama.2020.14545.

2. U.S. Department of Health and Human Services. The Surgeon General’s Call to Action to Control Hypertension. Washington, DC: U.S. Department of Health and Human Services, Office of the Surgeon General; 2020.

3. Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J. Adherence to single-pill versus free-equivalent combination therapy in hypertension: a systematic review and meta-analysis. Hypertension. 2021;77:692–705. https://doi.org/10.1161/HYPERTENSIONAHA.120.15781.

4. Chow CK, Atkins ER, Hillis GS, Nelson MR, Reid CM, Schlaich MP, et al. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial. Lancet. 2021;398:1043–52. https://doi.org/10.1016/S0140-6736(21)01922-X.

5. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326:1427–0. https://doi.org/10.1136/bmj.326.7404.1427.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of antihypertensive therapy in the Russian population: data from the ESSE-RF3 study;Rational Pharmacotherapy in Cardiology;2024-02-22

2. Effectiveness of Hypertension Management Strategies in SPRINT‐Eligible US Adults: A Simulation Study;Journal of the American Heart Association;2024-01-16

3. Use of antihypertensive drug classes and combination therapies during the COVID-19 pandemic in Poland: a cross-sectional, nation-wide study 2019-2021;Polish Archives of Internal Medicine;2024-01-02

4. Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial;Hypertension;2023-08